Streetbeat News

Revenues

IESC

IES Holdings, Inc. (IESC) has acquired Greiner Industries, a structural steel fabrication and services company with 2023 revenue of approximately $58 million. The acquisition includes Greiner's facilities, spanning 450,000 square feet on a 60-acre campus. Greiner will join IES's Infrastructure Solutions segment but will continue operating under its own name. The acquisition aims to expand IES's geographic footprint, product offerings, and capacity in the Mid-Atlantic market, including the Virginia data center market. Greiner's experienced workforce and leadership, including Vice President of Operations Rick Sine, will join IES.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:37 pm

AEHL

Antelope Enterprise announced its preliminary full-year 2023 revenue, reaching $70.4 million. This financial update is crucial for investors monitoring AEHL's performance.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:34 pm

CG

TEVA

Teva Pharmaceutical Industries Ltd. (TEVA) and Launch Therapeutics have entered a clinical collaboration to accelerate the development of Teva's Dual-Action Asthma Rescue Inhaler (TEV-‘248). Additionally, Teva and Abingworth, part of Carlyle (CG), announced a strategic development funding agreement providing Teva up to $150 million to support the TEV-‘248 program. This collaboration aims to expedite the clinical research program, with Launch Therapeutics leading the operational execution of clinical trials. Teva retains responsibility for manufacturing, U.S. regulatory interactions, and commercialization. The funding from Abingworth will be recognized by Teva as a reduction in R&D expenses, and Abingworth is eligible for payments based on sales if TEV-‘248 receives FDA approval.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:33 pm

NVX

NOVONIX Limited (NASDAQ:NVX) has been selected to receive a $103 million tax credit under the Qualifying Advanced Energy Project Allocation Program, supported by the U.S. Department of Energy. This tax credit aims to bolster the production of critical battery materials at NOVONIX's Riverside facility in Chattanooga, Tennessee. The credit is part of efforts to promote clean energy manufacturing, job creation, and U.S. domestic production of vital clean-energy products. NOVONIX's selection highlights its ongoing support from the U.S. government and marks a significant milestone in its financing strategy and commitment to innovation and sustainability in North America.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:30 pm

BLDP

Ballard Power Systems (NASDAQ:BLDP) (TSX:BLDP) announced a Long Term Supply Agreement with Solaris Bus & Coach for 1,000 hydrogen fuel cell engines through 2027, marking the company's largest order. The engines will power Solaris buses across Europe, supporting the transition to zero-emission public transport. The order includes after-market and extended warranty services, with deliveries starting in 2024. This agreement strengthens Ballard's position in the European transit bus market and supports the decarbonization of urban fleets.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:16 pm

LFCR

Lifecore projects its FY24 revenue to be in the range of $125M-$130M.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:16 pm

AMTX

Aemetis, Inc. (NASDAQ:AMTX) has implemented the Microsoft Dynamics ERP system to support its operations and expansion projects in the U.S. and India. This move is part of Aemetis' Five Year Plan, aiming for over $1.9B in revenues and $645M in EBITDA by the fifth year. The ERP system will support various projects, including the Aemetis Biogas business, the India biodiesel business IPO, the Riverbank sustainable aviation fuel production plant, the Riverbank carbon sequestration project, and the Keyes ethanol plant upgrade.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:12 pm

MNR

Mach Natural Resources reported a fiscal year 2023 net income of $347 million and revenues of $762 million.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:11 pm

SBFM

Sunshine Biopharma reported its FY23 sales at $24.09 million, surpassing the estimated $22.51 million. However, its EPS showed a loss of $(0.19), which was more than the estimated loss of $(0.16).

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:11 pm

MIST

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) announced its plans to present data on etripamil, a cardiovascular medicine, at the American College of Cardiology (ACC24) and European Heart Rhythm Association (EHRA) annual meetings. The presentations will cover the efficacy and safety of etripamil nasal spray for treating symptomatic Supraventricular Tachycardia and will include both oral and poster presentations.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:02 pm